PLSCR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.310000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.145900E-02
Normal-vs-Stage2
1.259400E-01
Normal-vs-Stage3
7.222300E-02
Normal-vs-Stage4
1.239200E-01
Stage1-vs-Stage2
1.910000E-01
Stage1-vs-Stage3
5.059800E-01
Stage1-vs-Stage4
9.592800E-01
Stage2-vs-Stage3
1.190160E-01
Stage2-vs-Stage4
2.662200E-01
Stage3-vs-Stage4
5.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.603900E-02
Normal-vs-AfricanAmerican
3.293000E-01
Normal-vs-Asian
4.861200E-01
Caucasian-vs-AfricanAmerican
5.312600E-01
Caucasian-vs-Asian
9.184300E-02
AfricanAmerican-vs-Asian
6.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.023630E-01
Normal-vs-Female
5.734400E-02
Male-vs-Female
7.774000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.550400E-01
Normal-vs-Age(41-60Yrs)
2.053000E-01
Normal-vs-Age(61-80Yrs)
4.821800E-02
Normal-vs-Age(81-100Yrs)
2.337600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.580800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.618200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.518800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.607600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.458370E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.337900E-02
Normal-vs-Daily Drinker
7.134000E-02
Normal-vs-Weekly Drinker
1.074610E-01
Normal-vs-Occasional Drinker
1.629350E-01
Normal-vs-Social Drinker
2.254800E-01
Non Drinker-vs-Daily Drinker
9.754400E-01
Non Drinker-vs-Weekly Drinker
7.252600E-01
Non Drinker-vs-Occasional Drinker
4.659200E-01
Non Drinker-vs-Social Drinker
4.782000E-01
Daily Drinker-vs-Weekly Drinker
7.471600E-01
Daily Drinker-vs-Occasional Drinker
5.176600E-01
Daily Drinker-vs-Social Drinker
5.305200E-01
Weekly Drinker-vs-Occasional Drinker
7.728400E-01
Weekly Drinker-vs-Social Drinker
7.646000E-01
Occasional Drinker-vs-Social Drinker
9.658400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.210800E-01
Normal-vs-Grade 2
3.640100E-02
Normal-vs-Grade 3
5.378000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.815700E-03
Grade 1-vs-Grade 3
1.502100E-02
Grade 1-vs-Grade 4
3.210800E-01
Grade 2-vs-Grade 3
5.866000E-01
Grade 2-vs-Grade 4
3.640100E-02
Grade 3-vs-Grade 4
5.378000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.367600E-02
Normal-vs-NonDiabetic
9.140200E-02
Diabetic-vs-NonDiabetic
3.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.005040E-01
Normal-vs-NoPancreatitis
7.822000E-02
Pancreatitis-vs-NoPancreatitis
6.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.424400E-01
Normal-vs-N1
1.430030E-01
N0-vs-N1
6.369600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.865390E-01
Normal-vs-TP53-NonMutant
5.480200E-02
TP53-Mutant-vs-TP53-NonMutant
1.824160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
